FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
29/11/2024
Voltar para busca
Dado oficial do USPTO
ZACTIFY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
29/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
04/06/2021
Data de registro
28/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/05/2024
Última transação
28/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
FARRELL, ANNE
Unidade examinadora
M90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/11/2024
FIMP
FINAL DISPOSITION PROCESSED
10/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
28/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2024
PUBO
PUBLISHED FOR OPPOSITION
12/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
11/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/01/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
31/05/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/02/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/02/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
18/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/04/2022
GNSL
LETTER OF SUSPENSION E-MAILED
01/04/2022
CNSL
SUSPENSION LETTER WRITTEN
01/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/12/2021
RFNT
REFUSAL PROCESSED BY IB
19/12/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/11/2021
RFRR
REFUSAL PROCESSED BY MPU
26/11/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/10/2021
CNRT
NON-FINAL ACTION WRITTEN
26/10/2021
DOCK
ASSIGNED TO EXAMINER
19/10/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/09/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
20/09/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZACTIFY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.